One thing nice about investing in the small biotech space is that there is never a dull momentThis is especially true during earnings season, when there is a litany of quarterly results to digest along with the usual spate of trial data, conference presentations, Food and Drug Administration (FDA) actions and new analyst ratingsThere has been quit...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.